within Pharmacolibrary.Drugs.ATC.R;

model R03CC02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.225,
    adminDuration  = 600,
    adminMass      = 0.004,
    adminCount     = 1,
    Vd             = 0.156,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.007166666666666667,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Salbutamol (also known as albuterol) is a short-acting Î²2 adrenergic receptor agonist used primarily for the relief and prevention of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is approved for use as a bronchodilator and is commonly administered via inhalation, but can also be given orally or intravenously in certain scenarios.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following oral administration.</p><h4>References</h4><ol><li><a href='https://dx.doi.org/10.1111/j.1365-2125.1985.tb02410.x'>10.1111/j.1365-2125.1985.tb02410.x</a> Values extracted from: Davies DS, Harding SM, Richards D, Tucker GT, Williams BO. The pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate in man. Br J Clin Pharmacol. 1985 Jun;19(6):649-59. Oral bioavailability is variable and estimated around 50%. ka and Tlag estimated from mean absorption characteristics reported in the study.</li></ol></body></html>",
    revisions = "<html><body><ul><li>03/06/2025 model generated from PK parameters and knowledge obtained by LLM gpt-4.1 and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R03CC02;
